X4 Pharmaceuticals Inc — 貸借対照表 (NASDAQ:XFOR) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 122.87 M117.18 M155.59 M147.26 M146.45 M290.46 M 負債合計 50.07 M52.76 M81.53 M96.16 M124.3 M104.17 M 純資産合計 72.8 M64.41 M74.05 M51.1 M22.15 M186.29 M 負債および純資産合計 122.87 M117.18 M155.59 M147.26 M146.45 M290.46 M 有利子負債合計 37.77 M33.93 M33.62 M54.57 M77.66 M75.99 M 純負債 -40.94 M-42.8 M-84.61 M-55.92 M-24.44 M-177.01 M

ニュース

Stifel、治験進展を受けX4 Pharmaceuticals株の投資判断を継続

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

X4 Pharmaceuticalsがリアリンク・グローバル・ヘルスケア・カンファレンスで希少血液学への戦略転換を発表

X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology

Guggenheim initiates X4 Pharmaceuticals stock with buy rating

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

EMA委員会、超希少疾患WHIM症候群治療薬mavorixaforを支持

EMA panel backs mavorixafor for ultra-rare WHIM syndrome

Vericel Corporation (VCEL) Matches Q4 Earnings Estimates

X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy